Brief: Allergy Therapeutics Says Further Advancement Via Patient Cohorts In Phase I/IIa VLP Peanut PROTECT Trial

Allergy Therapeutics

17/09/2024 07:48

Sept 17 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * ALLERGY THERAPEUTICS PLC: FURTHER ADVANCEMENT THROUGH
PATIENT
COHORTS IN PHASE I/IIA VLP PEANUT PROTECT TRIAL
    * ALLERGY THERAPEUTICS: NO RELEVANT SAFETY OR TOLERABILITY
FINDINGS OBSERVED IN EITHER PEANUT ALLERGIC PATIENTS OR HEALTHY
SUBJECTS AT HIGHER DOSES

Source text for Eikon:  ID:nRSQ3864Ea 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))